Expertise in
1
conditions

Peter M. Chang

No. 201, Sec. 2, Shipai Road, 
Taipei, TNQ, TW 
Expertise in
1
conditions
No. 201, Sec. 2, Shipai Road, 
Taipei, TNQ, TW 

Overview

Peter Chang practices practicing medicine in Taipei, Taiwan.

Mr. Chang is highly rated in 1 condition, according to our data. His clinical expertise encompasses Head and Neck Squamous Cell Carcinoma (HNSCC), Lung Cancer, Cholangiocarcinoma (Bile Duct Cancer), and Tongue Cancer.

He is actively involved in clinical research, co-authoring 84 peer reviewed articles and participating in 1 clinical trial.

Gender

Male

Locations

No. 201, Sec. 2, Shipai Road, Taipei, TNQ 11217, Taiwan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Phase III, Double-Blind, Placebo-Controlled Study of Post-Operative Adjuvant Concurrent Chemo-Radiotherapy With or Without Nimotuzumab for Stage III/IV Head & Neck Squamous Cell Cancer
Phase III, Double-Blind, Placebo-Controlled Study of Post-Operative Adjuvant Concurrent Chemo-Radiotherapy With or Without Nimotuzumab for Stage III/IV Head & Neck Squamous Cell Cancer
Enrollment Status: Unknown
Publish Date: January 09, 2024
Intervention Type: Drug
Study Drug: Nimotuzumab
Study Phase: Phase 3

84 Total Publications

Nicotine drives lung cancer progression by suppressing cuproptosis through the LIAS-DLAT axis and promoting M2 macrophage polarization.
Nicotine drives lung cancer progression by suppressing cuproptosis through the LIAS-DLAT axis and promoting M2 macrophage polarization.
Journal: Free radical biology & medicine
Published: April 23, 2026

Frequently Asked Questions about Peter M. Chang

Is Peter M. Chang a top-rated expert for Head and Neck Squamous Cell Carcinoma (HNSCC)?

MediFind is an objective health platform that identifies experts based on real-world data. Peter M. Chang is classified as an Advanced expert for Head and Neck Squamous Cell Carcinoma (HNSCC), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Peter M. Chang participate in research or clinical trials?

Yes. Peter M. Chang has published 84 articles and abstracts on conditions like Head and Neck Squamous Cell Carcinoma (HNSCC). You can view a list of Peter M. Chang's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Chang's expertise for a condition
ConditionClose
      View All 7 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile